In context of this conclusion, and as a therapeutic approach, tumor cells were intracranially injected into ICAM-1 deficient mice leading to a longer survival with a lower overall tumor volume comparet to the wild type [25]. This evidence concerns the gene ICAM1 and neoplasm.